These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12215754)

  • 21. Comparative pharmacology of site directed antithrombin agents. Implication in drug development.
    Callas D; Fareed J
    Thromb Haemost; 1995 Jul; 74(1):473-81. PubMed ID: 8578509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease.
    Guzzetta NA; Miller BE; Todd K; Szlam F; Moore RH; Brosius KK; Wilson EC; Cohen AM; Tosone SR
    Anesth Analg; 2006 Nov; 103(5):1131-8. PubMed ID: 17056945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
    Davis C; Robertson C; Shivakumar S; Lee M
    J Can Dent Assoc; 2013; 79():d74. PubMed ID: 23920075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific thrombin inhibitors ... only one tool of the antithrombotic armamentarium.
    Van De Werf F
    Eur Heart J; 1999 Apr; 20(7):479-80. PubMed ID: 10365282
    [No Abstract]   [Full Text] [Related]  

  • 25. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct thrombin inhibitors.
    O'Brien PJ; Mureebe L
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):5-11. PubMed ID: 21335484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modification of thrombin activity by synthetic serine proteinase inhibitors].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):471-82. PubMed ID: 4121340
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test?
    de Gaetano G; Cerletti C
    J Thromb Haemost; 2007 Sep; 5(9):1835-8. PubMed ID: 17723122
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors.
    Hauptmann J; Kaiser B; Nowak G; Stürzebecher J; Markwardt F
    Thromb Haemost; 1990 Apr; 63(2):220-3. PubMed ID: 2363124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of fibrinogen by thrombin time - with special reference to the effect of anti-thrombin].
    Isobe J; Taharaguchi T; Watanabe H; Shima E; Hamai Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):109. PubMed ID: 4475718
    [No Abstract]   [Full Text] [Related]  

  • 31. Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position.
    Feng DM; Gardell SJ; Lewis SD; Bock MG; Chen Z; Freidinger RM; Naylor-Olsen AM; Ramjit HG; Woltmann R; Baskin EP; Lynch JJ; Lucas R; Shafer JA; Dancheck KB; Chen IW; Mao SS; Krueger JA; Hare TR; Mulichak AM; Vacca JP
    J Med Chem; 1997 Nov; 40(23):3726-33. PubMed ID: 9371237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology consultation on monitoring direct thrombin inhibitors and overcoming their effects in bleeding patients.
    Winkler AM; Tormey CA;
    Am J Clin Pathol; 2013 Nov; 140(5):610-22. PubMed ID: 24124139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of inhibitors of thrombin on porcine aortic smooth muscle cells in primary culture.
    Melzig M; Harms C; Teuscher E; Voigt B; Wagner G
    Biomed Biochim Acta; 1986; 45(9):1199-202. PubMed ID: 3814109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complications in peripheral vascular interventions: emerging role of direct thrombin inhibitors.
    Shammas NW
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):165-71. PubMed ID: 15713917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of heparin in thrombin inhibition by antithrombin].
    Bleyl H; Róka L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):719-30. PubMed ID: 75141
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thrombin inhibitors--current developments and clinical relevance].
    Haas S; Bode Ch
    Hamostaseologie; 2002 Aug; 22(3):5-6. PubMed ID: 12215754
    [No Abstract]   [Full Text] [Related]  

  • 37. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct thrombin inhibitors: clinical uses, mechanism of action, and laboratory measurement.
    Rhea JM; Molinaro RJ
    MLO Med Lab Obs; 2011 Aug; 43(8):20, 22, 24. PubMed ID: 21936409
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel anticoagulants based on direct inhibition of thrombin and factor Xa.
    Gardell SJ; Sanderson PE
    Coron Artery Dis; 1998; 9(2-3):75-81. PubMed ID: 9647407
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthetic direct thrombin inhibitors in unstable angina - more questions than answers.
    Oberhoff M; Karsch KR
    Eur Heart J; 1999 Aug; 20(15):1058-60. PubMed ID: 10413631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.